(Q51000121)

26 March 2018

title

Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype. (English)

1 reference

26 March 2018

author name string

M L Dahl

series ordinal

1

1 reference

26 March 2018

L Bertilsson

series ordinal

2

1 reference

26 March 2018

C Nordin

series ordinal

3

1 reference

26 March 2018

publication date

1 February 1996

1 reference

26 March 2018

published in

Psychopharmacology

1 reference

26 March 2018

volume

123

1 reference

26 March 2018

page(s)

315-319

1 reference

26 March 2018

issue

4

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/bf02246640

exact match

0 references

cites work

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246640

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246640

CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246640

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

21 January 2018

1 reference

12 December 2020

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

12 December 2020

A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine

1 reference

12 December 2020

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

12 December 2020

Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon

1 reference

12 December 2020

Polymorphic hydroxylation of debrisoquine

1 reference

12 December 2020

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation

1 reference

12 December 2020

Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man

1 reference

12 December 2020

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

1 reference

12 December 2020

Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.

1 reference

12 December 2020

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

1 reference

12 December 2020

CYP2D6 genotype determination in the Danish population.

1 reference

12 December 2020

Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations

1 reference

12 December 2020

Plasma 10-hydroxynortriptyline in elderly depressed patients

1 reference

12 December 2020

Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring

1 reference

12 December 2020

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

1 reference

12 December 2020

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes

1 reference

12 December 2020

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis

1 reference

12 December 2020

Plasma Level Monitoring of Tricyclic Antidepressant Therapy

1 reference

12 December 2020

Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline

1 reference

12 December 2020

Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics

1 reference

12 December 2020

Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Gender effects in pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

12 December 2020

Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism

1 reference

12 December 2020

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

1 reference

12 December 2020

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

12 December 2020

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246640

1 reference

26 March 2018

PubMed ID

8867869

1 reference

26 March 2018